Literature DB >> 33431194

Minimal Clinically Important Difference of the PROMIS Upper-Extremity Computer Adaptive Test and QuickDASH for Ligament Reconstruction Tendon Interposition Patients.

Nikolas H Kazmers1, Yuqing Qiu2, Zhining Ou2, Angela P Presson2, Andrew R Tyser3, Yue Zhang2.   

Abstract

PURPOSE: To calculate the minimal clinically important difference (MCID) of the Patient-Reported Outcomes Measurement Information System (PROMIS) Upper Extremity Computer Adaptive Test (UE CAT) and Quick-Disabilities of the Arm, Shoulder, and Hand (QuickDASH) for ligament reconstruction tendon interposition (LRTI) patients.
METHODS: Adult patients treated with LRTI for trapeziometacarpal OA by fellowship-trained hand surgeons between December 2014 and February 2018 at an academic tertiary institution were included. Outcomes were prospectively collected at each visit by tablet computer, including the QuickDASH, PROMIS UE, Pain Interference, Depression, and Anxiety CATs. Inclusion required a response to the anchor question "How much relief and/or improvement do you feel you have experienced as a result of your treatment?" on a 6-option Likert scale, as well as preoperative (≤120 days before surgery) and follow-up (2-26 weeks) outcomes. We calculated MCID both by an anchor-based approach using the mean score of the minimal change group, and with the 0.5 SD method.
RESULTS: Of 145 included participants, mean age was 63 ± 8 years and 74% were female. Anchor-based MCID estimates for the total cohort were 4.2 for the PROMIS UE CAT and 8.8 for the QuickDASH. The MCID estimates using the 0.5 SD method were 4.8 and 11.7, respectively.
CONCLUSIONS: We propose MCID values of 4.2 to 4.8 for the PROMIS UE CAT and 8.8 to 11.7 for the QuickDASH when powering clinical studies or when assessing improvement among a cohort of patients who have undergone LRTI surgery. CLINICAL RELEVANCE: Minimal clinically important difference estimates are helpful when interpreting clinical outcomes after LRTI and for powering prospective trials.
Copyright © 2021 American Society for Surgery of the Hand. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biopsychosocial; PROMIS; Upper-Extremity CAT; ligament reconstruction tendon interposition; minimal clinically important difference

Mesh:

Year:  2021        PMID: 33431194     DOI: 10.1016/j.jhsa.2020.11.007

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  5 in total

1.  Establishing the Minimal Clinically Important Difference and Substantial Clinical Benefit for the Pain Visual Analog Scale in a Postoperative Hand Surgery Population.

Authors:  Dustin J Randall; Yue Zhang; Haojia Li; James C Hubbard; Nikolas H Kazmers
Journal:  J Hand Surg Am       Date:  2022-05-27       Impact factor: 2.342

2.  Establishing the Substantial Clinical Benefit in a Non-Shoulder Hand and Upper Extremity Population for the QuickDASH and PROMIS Upper Extremity and Physical Function Computer Adaptive Tests.

Authors:  James C Hubbard; Yue Zhang; Yuqing Qiu; Minkyoung Yoo; Andrew R Stephens; Michelle Zeidan; Nikolas H Kazmers
Journal:  J Hand Surg Am       Date:  2022-02-23       Impact factor: 2.342

3.  Evaluation of the PROMIS Upper Extremity Against Validated Patient-Reported Outcomes in Patients With Early Carpometacarpal Osteoarthritis.

Authors:  Edgar Garcia-Lopez; Douglas C Moore; Deborah E Kenney; Amy L Ladd; Arnold-Peter C Weiss; Joseph J Crisco
Journal:  J Hand Surg Am       Date:  2022-05-05       Impact factor: 2.342

4.  The minimal clinically important difference of the Patient-Reported Outcomes Measurement Information System (PROMIS) physical function and upper extremity computer adaptive tests and QuickDASH in the setting of elbow trauma.

Authors:  Dustin J Randall; Yue Zhang; Andrew P Harris; Yuqing Qiu; Haojia Li; Andrew R Stephens; Nikolas H Kazmers
Journal:  JSES Int       Date:  2021-08-08

Review 5.  Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measures.

Authors:  Caroline B Terwee; John Devin Peipert; Robert Chapman; Jin-Shei Lai; Berend Terluin; David Cella; Philip Griffith; Lidwine B Mokkink
Journal:  Qual Life Res       Date:  2021-07-10       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.